Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation
- PMID: 17936560
- DOI: 10.1016/j.ccr.2007.09.007
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation
Abstract
It is believed that Mdm2 suppresses p53 in two ways: transcriptional inhibition by direct binding, and degradation via its E3 ligase activity. To study these functions physiologically, we generated mice bearing a single-residue substitution (C462A) abolishing the E3 function without affecting p53 binding. Unexpectedly, homozygous mutant mice died before E7.5, and deletion of p53 rescued the lethality. Furthermore, reintroducing a switchable p53 by crossing with p53ER(TAM) mice surprisingly demonstrated that the mutant Mdm2(C462A) was rapidly degraded in a manner indistinguishable from that of the wild-type Mdm2. Hence, our data indicate that (1) the Mdm2-p53 physical interaction, without Mdm2-mediated p53 ubiquitination, cannot control p53 activity sufficiently to allow early mouse embryonic development, and (2) Mdm2's E3 function is not required for Mdm2 degradation.
Similar articles
-
Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction.PLoS One. 2012;7(5):e38212. doi: 10.1371/journal.pone.0038212. Epub 2012 May 29. PLoS One. 2012. PMID: 22666487 Free PMC article.
-
Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice.J Biol Chem. 2017 Dec 29;292(52):21614-21622. doi: 10.1074/jbc.RA117.000122. Epub 2017 Nov 9. J Biol Chem. 2017. PMID: 29123033 Free PMC article.
-
Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.Oncogene. 2015 Jan 15;34(3):281-9. doi: 10.1038/onc.2013.557. Epub 2014 Jan 13. Oncogene. 2015. PMID: 24413081
-
Unlocking the Mdm2-p53 loop: ubiquitin is the key.Cell Cycle. 2008 Feb 1;7(3):287-92. doi: 10.4161/cc.7.3.5358. Epub 2007 Nov 25. Cell Cycle. 2008. PMID: 18235222 Review.
-
Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.Anticancer Agents Med Chem. 2015;16(2):174-89. doi: 10.2174/1871520615666150907093358. Anticancer Agents Med Chem. 2015. PMID: 26343143 Review.
Cited by
-
DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction.Oncotarget. 2012 Sep;3(9):1026-35. doi: 10.18632/oncotarget.640. Oncotarget. 2012. PMID: 22976441 Free PMC article.
-
Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis.Cell Rep. 2016 Sep 6;16(10):2618-2629. doi: 10.1016/j.celrep.2016.08.014. Epub 2016 Aug 25. Cell Rep. 2016. PMID: 27568562 Free PMC article.
-
Characterization of cancer-associated missense mutations in MDM2.Mol Cell Oncol. 2015 Dec 10;3(2):e1125986. doi: 10.1080/23723556.2015.1125986. eCollection 2016 Mar. Mol Cell Oncol. 2015. PMID: 27308622 Free PMC article.
-
MTA1 coregulator regulates p53 stability and function.J Biol Chem. 2009 Dec 11;284(50):34545-52. doi: 10.1074/jbc.M109.056499. Epub 2009 Oct 16. J Biol Chem. 2009. PMID: 19837670 Free PMC article.
-
Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53.Br J Cancer. 2010 Jul 13;103(2):186-95. doi: 10.1038/sj.bjc.6605739. Epub 2010 Jun 29. Br J Cancer. 2010. PMID: 20588277 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous